189 related articles for article (PubMed ID: 29087392)
1. Putting Evidence into Practice: IBD Surveillance, Chromoendoscopy and Future Directions.
Ten Hove JR; Bernstein CN; Oldenburg B
Am J Gastroenterol; 2018 Mar; 113(3):313-316. PubMed ID: 29087392
[No Abstract] [Full Text] [Related]
2. A roadmap to the implementation of chromoendoscopy in inflammatory bowel disease colonoscopy surveillance practice.
Sanduleanu S; Kaltenbach T; Barkun A; McCabe RP; Velayos F; Picco MF; Laine L; Soetikno R; McQuaid KR
Gastrointest Endosc; 2016 Jan; 83(1):213-22. PubMed ID: 26364967
[No Abstract] [Full Text] [Related]
3. Chromoendoscopy for colorectal cancer surveillance in patients with inflammatory bowel disease.
Shah SA; Rubin DT; Farraye FA
Curr Gastroenterol Rep; 2014 Sep; 16(9):407. PubMed ID: 25113042
[TBL] [Abstract][Full Text] [Related]
4. An atlas of the nonpolypoid colorectal neoplasms in inflammatory bowel disease.
Soetikno R; Sanduleanu S; Kaltenbach T
Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):483-520. PubMed ID: 24975538
[TBL] [Abstract][Full Text] [Related]
5. Chromoendoscopy for Surveillance in Inflammatory Bowel Disease Does Not Increase Neoplasia Detection Compared With Conventional Colonoscopy With Random Biopsies: Results From a Large Retrospective Study.
Mooiweer E; van der Meulen-de Jong AE; Ponsioen CY; Fidder HH; Siersema PD; Dekker E; Oldenburg B
Am J Gastroenterol; 2015 Jul; 110(7):1014-21. PubMed ID: 25823770
[TBL] [Abstract][Full Text] [Related]
6. Toward a consensus on endoscopic surveillance of patients with colonic inflammatory bowel disease.
Shergill AK; Farraye FA
Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):469-81. PubMed ID: 24975537
[TBL] [Abstract][Full Text] [Related]
7. Surveillance in inflammatory bowel disease: chromoendoscopy and digital mucosal enhancement.
Naymagon S; Marion JF
Gastrointest Endosc Clin N Am; 2013 Jul; 23(3):679-94. PubMed ID: 23735110
[TBL] [Abstract][Full Text] [Related]
8. Beyond standard image-enhanced endoscopy confocal endomicroscopy.
Teubner D; Kiesslich R; Matsumoto T; Rey JW; Hoffman A
Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):427-34. PubMed ID: 24975533
[TBL] [Abstract][Full Text] [Related]
9. Surveillance of patients with inflammatory bowel disease.
Yu JX; East JE; Kaltenbach T
Best Pract Res Clin Gastroenterol; 2016 Dec; 30(6):949-958. PubMed ID: 27938789
[TBL] [Abstract][Full Text] [Related]
10. Chromoendoscopy for Dysplasia Surveillance in Inflammatory Bowel Disease.
Flynn AD; Valentine JF
Inflamm Bowel Dis; 2018 Jun; 24(7):1440-1452. PubMed ID: 29668929
[TBL] [Abstract][Full Text] [Related]
11. Optimizing the quality of endoscopy in inflammatory bowel disease: focus on surveillance and management of colorectal dysplasia using interactive image- and video-based teaching.
Kaltenbach TR; Soetikno RM; DeVivo R; Laine LA; Barkun A; McQuaid KR;
Gastrointest Endosc; 2017 Dec; 86(6):1107-1117.e1. PubMed ID: 28818507
[TBL] [Abstract][Full Text] [Related]
12. White light endoscopy versus chromoendoscopy for the detection of dysplasia during inflammatory bowel disease surveillance with colonoscopy.
Vaziri H; Anderson JC
Gastroenterology; 2015 Nov; 149(6):1630-2. PubMed ID: 26428464
[No Abstract] [Full Text] [Related]
13. Detection of nonpolypoid colorectal neoplasia using magnifying endoscopy in colonic inflammatory bowel disease.
Oka S; Tanaka S; Chayama K
Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):405-17. PubMed ID: 24975531
[TBL] [Abstract][Full Text] [Related]
14. Challenges in designing a randomized trial of surveillance colonoscopy in IBD.
Bernstein CN
Inflamm Bowel Dis; 1998 May; 4(2):132-41. PubMed ID: 9589298
[No Abstract] [Full Text] [Related]
15. Paradigm Shift in the Surveillance and Management of Dysplasia in Inflammatory Bowel Disease (West).
Soetikno R; Kaltenbach T; McQuaid KR; Subramanian V; Kumar R; Barkun AN; Laine L
Dig Endosc; 2016 Apr; 28(3):266-73. PubMed ID: 26866420
[TBL] [Abstract][Full Text] [Related]
16. Miles to Go on the SCENIC Route: Should Chromoendoscopy Become the Standard of Care in IBD Surveillance?
Higgins PD
Am J Gastroenterol; 2015 Jul; 110(7):1035-7. PubMed ID: 26148262
[TBL] [Abstract][Full Text] [Related]
17. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease.
Laine L; Kaltenbach T; Barkun A; McQuaid KR; Subramanian V; Soetikno R;
Gastroenterology; 2015 Mar; 148(3):639-651.e28. PubMed ID: 25702852
[No Abstract] [Full Text] [Related]
18. Reflecting on the SCENIC recommendations for chromoendoscopy and targeted biopsy.
Soetikno R; Nguyen-Vu T; Subramanian V; Kaltenbach T
Lancet Gastroenterol Hepatol; 2019 Apr; 4(4):262-264. PubMed ID: 30860062
[No Abstract] [Full Text] [Related]
19. Real-life chromoendoscopy for neoplasia detection and characterisation in long-standing IBD.
Carballal S; Maisterra S; López-Serrano A; Gimeno-García AZ; Vera MI; Marín-Garbriel JC; Díaz-Tasende J; Márquez L; Álvarez MA; Hernández L; De Castro L; Gordillo J; Puig I; Vega P; Bustamante-Balén M; Acevedo J; Peñas B; López-Cerón M; Ricart E; Cuatrecasas M; Jimeno M; Pellisé M;
Gut; 2018 Jan; 67(1):70-78. PubMed ID: 27612488
[TBL] [Abstract][Full Text] [Related]
20. "That was me" a patient's perspective on flat lesion in inflammatory bowel disease.
Zarrow R; Zarrow A; Zarrow H
Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):349-51. PubMed ID: 24975526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
